GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-AstraZeneca vaccine fails to lift euro zone gvt bonds

Mon, 23rd Nov 2020 12:11

* Euro zone periphery govt bond yields http://tmsnrt.rs/2ii2Bqr
(Updates prices, adds reference to the EU's 15-year COVID-19
recovery plan bond)

By Olga Cotaga

LONDON, Nov 23 (Reuters) - Euro zone government bonds were
little changed despite positive news on a AstraZeneca
vaccine on Monday as investors focused on the major economies
under strict lockdowns and the fact that COVID-19 cases are not
receding.

Britain’s AstraZeneca said its vaccine for the novel
coronavirus could be around 90% effective without any serious
side effects, making it the latest pharmaceutical company to
report on late stage results.

But more than 58.32 million people are reported to be
infected by the coronavirus globally and 1,385,595? have died,
according to a Reuters tally.

And many of Germany's 16 federal states favour extending a
partial shutdown meant to slow the spread of the COVID-19
pandemic.

"The covid pandemic, and associated social distancing
measures, remains front and centre on investors' minds," said
ING analysts in a note to clients. "This, combined with still
cautious central banks, would reduce euro zone rates upside."

Benchmark German 10-year Bund yields were last flat at
-0.577%, after falling to a two-week low of -0.592%.
Peripheral yields were lower, with Italian 10-year BTP yields
down 1.3 basis points at 0.583%, close to its recent
0.57% record low.

Portuguese 10-year government bond yields were flat, but at
0.031%, they were close to negative territory.

Euro zone business activity contracted this month as renewed
lockdowns forced much of the bloc's dominant service industry to
close temporarily. Investors were indifferent; yields were
little changed.

The spread between German and Italian government bond yields
-- essentially the premium Italy is paying for its
debt -- stood at 115.4 basis points, close to a two-and-a-half
year low.

ING analysts see the spread between euro zone and U.S.
government bond yields shrinking, too, given that "the current
wave is at an earlier stage in the U.S. and so we expect
pessimism to be the dominant tone in U.S. markets," they said.

The spread stood at -143 basis points, near
the half-year low touched earlier this month.

Elsewhere, the European Union hired a syndicate of banks for
the sale of a new 15-year bond as part of its 'SURE' COVID-19
recovery plan, according to a lead manager memo seen by Reuters.

The bond, labelled as a social bond, and due July 4 2035,
will be launched "in the near future, subject to market
conditions", the memo said, a phrase debt management offices
usually use a day before a sale.

Belgium raised 1.494 billion euros ($1.258 billion) in an
OLO (linear bond) auction on Monday, the Belgian debt agency
said.

Belgium's 10-year government bond yields were last steady at
-0.387%.

Credit-rating agency Moody’s is expected to review Belgium's
rating on Friday, which currently stands at Aa3.

ING said a total of 14 billion euros were expected in
issuance this week from Belgium, the Netherlands and Italy.
Rabobank estimated a total of 11 billion euros.
(Reporting by Olga Cotaga, editing by Larry King and Angus
MacSwan)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.